Desmond Tutu Presents e-Health Call to Action


By Neil Versel, contributing editor

November 18, 2008 | Health-IT and other electronic communications tools can improve health quality, efficiency, and access to care at least as much in the developing world as in industrialized countries, but there must be coordinated and aligned local and global efforts to ensure interoperability, sustainability, and replicability.

Such is the message of a global “call to action” on e-health issued Tuesday.

“To achieve substantial progress on improving health quality, access, affordability, and efficiency, nations must share and work toward a global eHealth vision,” reads the action statement, which is the product of Making the eHealth Connection: Global Partnerships, Local Solutions, a series of Rockefeller Foundation conferences held last summer in Bellagio, Italy. South African Nobel Peace Prize Laureate Desmond Tutu introduced the document Tuesday at the Global Ministerial Forum on Research and Health in Bamako, Mali.

Signatories, which include more than 100 representatives of health care organizations, health-IT vendors, national governments, universities, industry groups, and charitable foundations, call for technologies that are “person-centered, need-driven, promote health and disease prevention, and are interoperable, standards-based, collaborative, sustainable, scalable, reusable, and owned by in-country organizations.” International donors should be aligned, the document says, to help prevent the kind of fragmentation that has hampered health systems in the West.

Brooke Partridge, a facilitator of the Rockefeller Foundation’s week-long mobile health conference in July, calls the document “a fantastic representation of best practices.” Partridge, president and chief executive of Vital Wave Consulting (Palo Alto, Calif.), says interoperability so far has failed in the U.S. because multitudes of competing interests have not fully embraced such principles. “The developing world can learn a lot from [the mistakes of] the developed world,” Partridge says.

Signatories also ask for interoperability based on open standards, though the final document backed off a reliance solely on open source software contained in an earlier draft.

“I think it was important to us to make a clear distinction between open source and open standards,” says Rockefeller Foundation associate director Karl Brown, reached by phone from Bamako today. Open source refers to software code, while open standards are industrywide agreements that promote interoperability. “I think we recrafted the language in a way that is acceptable to all,” Brown says.

Brown believes it might be easier to achieve interoperability in developing countries than in the U.S. or Europe. “You don’t have all the legacy systems in place,” he says.

This notion of “leapfrogging” old technologies in areas with limited existing technology infrastructure came up often at the Bellagio conferences. “There’s an advantage to starting late,” Brown says.

A prime example of the “leapfrog” strategy is with mobile phones, which have gained wide acceptance among people in regions that never had much in the way of landlines, and a key component of the call to action is mobile technology.

“The potential of m-health as a part of e-health is enormous,” says Partridge. She noted that there are more than 3.5 billion mobile phones in use, suggesting that more than half of the world’s population has one. (See “Mobile Medicine for the Developing World.”)

Partridge says a collaboration between the United Nations Foundation and the UK-based Vodafone Foundation will launch an m-health alliance early next year to put some of these plans into action. Also in the works is an International Medical Informatics Association health-IT workforce training program (see “AMIA Announces Plans to Take Training Program Global”) and a technical working group to develop a strategy for a technology framework that could work in multiple countries, sources tell Digital HealthCare & Productivity.

 

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.